Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology

被引:117
作者
Baenziger, Stefan [1 ]
Heikenwalder, Mathias [2 ]
Johansen, Pal [3 ]
Schlaepfer, Erika [1 ]
Hofer, Ursula [1 ]
Miller, Regina C. [1 ]
Diemand, Simone [1 ]
Honda, Kenya [4 ,5 ]
Kundig, Thomas M. [3 ]
Aguzzi, Adriano [2 ]
Speck, Roberto F. [1 ]
机构
[1] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[4] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan
[5] Univ Tokyo, Fac Med, Tokyo 113, Japan
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED RNA; T-CELL-ACTIVATION; CYTOKINE INDUCTION; GERMINAL-CENTERS; DENDRITIC CELLS; INFECTION; PATHOGENESIS; TISSUE; TRANSLOCATION;
D O I
10.1182/blood-2008-04-151712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic immune activation is a major cause for progressive immunodeficiency in human immunodeficiency virus type-1 (HIV) infection. The underlying trigger, however, remains largely unknown. HIV single-stranded RNA is a potent immune activator by triggering Toll-like receptor (TLR) 7/8. Thus, we hypothesized that sustained TLR7 triggering induces chronic immune activation and thereby contributes to progressive immunodeficiency. We used the synthetic compound R848 or a mixture of uridine-rich HIV single-stranded (ss) RNA oligonucleotides-both are potent TLR7/8 agonists-to explore the effects of sustained TLR7 triggering on the murine lymphoid system. Sustained TLR7 triggering induced an immunopathology reminiscent of progressive lymphoid destruction in HIV disease; we observed lymphopenia, elevated proinflammatory cytokines, splenomegaly, contracted lymphoid subsets, and lymphoid microarchitecture alteration with reduced marginal zone B-lymphocytes. Upon exposure to inactivated vesiculo-stomatitis virus, antibody production was abolished, although splenic lymphocytes were activated and total IgG was elevated. Our data imply that HIV itself may directly contribute to immune activation and dysfunction by stimulating TLR7. Thus, manipulation of TLR7 signaling may be a potential strategy to reduce chronic hyper-immune activation and, thereby, disease progression in HIV infection. (Blood. 2009;113:377-388)
引用
收藏
页码:377 / 388
页数:12
相关论文
共 58 条
  • [1] Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection
    Accapezzato, D
    Francavilla, V
    Paroli, M
    Casciaro, M
    Chircu, LV
    Cividini, A
    Abrignani, S
    Mondelli, MU
    Barnaba, V
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07) : 963 - 972
  • [2] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
    Adachi, O
    Kawai, T
    Takeda, K
    Matsumoto, M
    Tsutsui, H
    Sakagami, M
    Nakanishi, K
    Akira, S
    [J]. IMMUNITY, 1998, 9 (01) : 143 - 150
  • [3] Induction of long-lived germinal centers associated with persisting antigen after viral infection
    Bachmann, MF
    Odermatt, B
    Hengartner, H
    Zinkernagel, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) : 2259 - 2269
  • [4] KINETIC-STUDIES OF THE MECHANISM OF THROMBOCYTOPENIA IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    BALLEM, PJ
    BELZBERG, A
    DEVINE, DV
    LYSTER, D
    SPRUSTON, B
    CHAMBERS, H
    DOUBROFF, P
    MIKULASH, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (25) : 1779 - 1784
  • [5] Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions
    Beignon, AS
    McKenna, K
    Skoberne, M
    Manches, O
    DaSilva, I
    Kavanagh, DG
    Larsson, M
    Gorelick, RJ
    Lifson, JD
    Bhardwaj, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) : 3265 - 3275
  • [6] Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment
    Bernstein, DI
    Harrison, CJ
    Tomai, MA
    Miller, RL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (06) : 844 - 849
  • [7] The immune response modifier resiquimod mimics CD40-induced B cell activation
    Bishop, GA
    Ramirez, LM
    Baccam, M
    Busch, LK
    Pederson, LK
    Tomai, MA
    [J]. CELLULAR IMMUNOLOGY, 2001, 208 (01) : 9 - 17
  • [8] Microbial translocation is a cause of systemic immune activation in chronic HIV infection
    Brenchley, Jason M.
    Price, David A.
    Schacker, Timothy W.
    Asher, Tedi E.
    Silvestri, Guido
    Rao, Srinivas
    Kazzaz, Zachary
    Bornstein, Ethan
    Lambotte, Olivier
    Altmann, Daniel
    Blazar, Bruce R.
    Rodriguez, Benigno
    Teixeira-Johnson, Leia
    Landay, Alan
    Martin, Jeffrey N.
    Hecht, Frederick M.
    Picker, Louis J.
    Lederman, Michael M.
    Deeks, Steven G.
    Douek, Daniel C.
    [J]. NATURE MEDICINE, 2006, 12 (12) : 1365 - 1371
  • [9] Interleukin-10 determines viral clearance or persistence in vivo
    Brooks, David G.
    Trifilo, Matthew J.
    Edelmann, Kurt H.
    Teyton, Luc
    McGavern, Dorian B.
    Oldstone, Michael B. A.
    [J]. NATURE MEDICINE, 2006, 12 (11) : 1301 - 1309
  • [10] Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection
    Chun, TW
    Carruth, L
    Finzi, D
    Shen, XF
    DiGiuseppe, JA
    Taylor, H
    Hermankova, M
    Chadwick, K
    Margolick, J
    Quinn, TC
    Kuo, YH
    Brookmeyer, R
    Zeiger, MA
    BarditchCrovo, P
    Siliciano, RF
    [J]. NATURE, 1997, 387 (6629) : 183 - 188